Sanjivani Paranteral Ltd. (SANJIVIN) Share Price Surges 9.89% Today

Sanjivani Paranteral Ltd. Share Price rises 9.89% to Rs 165.05, marking a significant gain in the micro-cap category.

Sanjivani Paranteral Ltd. Share Price has surged by 9.89% today, reaching Rs 165.05. This notable increase from the previous close of Rs 150.2 highlights the stock's strong performance in the micro-cap category, where it has surpassed the qualifying threshold of 8.1%. With a market capitalisation of Rs 182.61 crore, Sanjivani Paranteral Ltd. has captured investor attention, making it a top gainer in the Pharmaceuticals & Drugs industry. The data confirms the price event but does not establish a company-specific catalyst. Investors and analysts are closely monitoring the stock's movements, seeking insights into its future trajectory.

Sanjivani Paranteral Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 165.05
Previous Close	Rs 150.2
Today's Change	+Rs 14.85 (+9.89%)
Day Open	Rs 150
Day High	Rs 169
Day Low	Rs 150
Current Volume (BSE)	12,209
BSE Traded Volume	12,209
Combined NSE + BSE Volume	12,209
Turnover	Rs 0.2 crore
Market Capitalisation	Rs 182.61 crore
Market Cap Category	Micro Cap
Qualifying Threshold Cleared	8.1%

Today's trading session saw Sanjivani Paranteral Ltd. open at Rs 150, reaching a high of Rs 169 and a low of Rs 150, before closing at Rs 165.05. The stock's turnover stood at Rs 0.2 crore, with a total volume of 12,209 shares traded on the BSE. This volume indicates active participation, aligning with the day's significant price movement. As a micro-cap stock, Sanjivani Paranteral Ltd. cleared the qualifying threshold of 8.1%, reinforcing its position as a top performer in its category. The day's price action reflects a robust interest from market participants, driven by the stock's potential in the Healthcare sector. This performance sets the stage for further technical analysis to understand the underlying momentum and trends.

Sanjivani Paranteral Ltd. Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 182.61 crore
P/E Ratio	27.19x
P/B Ratio	3.82x
ROE	0%
ROCE	266.43%
EPS	Rs 5.52
Book Value Per Share	Rs 39.27
Dividend Yield	0%

Sanjivani Paranteral Ltd. was valued at a P/E ratio of 27.19x, a P/B ratio of 3.82x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 0% and ROCE of 266.43%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs 5.52, book value per share of Rs 39.27, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

Sanjivani Paranteral Ltd. holds a market capitalisation of Rs 182.61 crore, positioning it within the micro-cap segment. The company's P/E ratio of 27.19 is above the industry median of 18.4, indicating a relatively higher valuation. Its P/B ratio of 3.82 also surpasses the industry median of 1.84, suggesting a premium on its book value. Despite a ROE of 0%, the company boasts an impressive ROCE of 266.43%, far exceeding the industry median of 12.96%. The EPS of Rs 5.52 and book value of Rs 39.27 per share provide additional insights into the company's earnings and net worth. While the dividend yield is currently at 0%, the fundamental metrics highlight areas of strength and potential challenges, guiding investors in their assessment of the stock's value.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Companies in Benchmark	137
Company P/E Ratio	27.19x
Benchmark Median P/E	18.4x
Benchmark Average P/E	58.52x
Benchmark P/E Range	0x to 3,482.29x
Companies with P/E Data	137
Company P/B Ratio	3.82x
Benchmark Median P/B	1.84x
Company ROE	0%
Benchmark Median ROE	9.93%
Company ROCE	266.43%
Benchmark Median ROCE	12.96%
Company Market Capitalisation	Rs 182.61 crore
Benchmark Median Market Cap	Rs 151.12 crore

Sanjivani Paranteral Ltd. (SANJIVIN) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs. The numerical benchmark uses 137 same industry companies from the supplied master-data set.

Sanjivani Paranteral Ltd. (SANJIVIN) has a P/E ratio of 27.19x, which is above the benchmark median of 18.4x, a difference of +47.77%. The benchmark contains 137 companies with P/E data, ranging from 0x to 3,482.29x. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Sanjivani Paranteral Ltd. (SANJIVIN) has a ROE of 0%, which is below the benchmark median of 9.93%, a difference of -100%. Sanjivani Paranteral Ltd. (SANJIVIN) has a ROCE of 266.43%, which is above the benchmark median of 12.96%, a difference of +1,955.79%.

Track today's top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

Operating within the Healthcare sector and Pharmaceuticals & Drugs industry, Sanjivani Paranteral Ltd. is part of a competitive landscape with 137 companies in the same industry. The company's P/E ratio of 27.19 is above the industry median of 18.4, reflecting a higher valuation compared to its peers. However, its ROE of 0% is below the industry median of 9.93%, indicating room for improvement in shareholder returns. The company's ROCE of 266.43% significantly outpaces the industry median of 12.96%, showcasing its efficiency in capital utilisation. With a market cap of Rs 182.61 crore, Sanjivani Paranteral Ltd. is positioned among smaller players in the industry, offering unique opportunities and challenges in the sector.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
BIO MEDICA LABORATORIES L	BMLL-SM	177.87	18.16	9.81	13.67	10.17
Accretion Pharmaceuticals Ltd.	ACCPL-ST	177.86	18.4	3.25	27.18	12.62
Brooks Laboratories Ltd.	BROOKS-BE	189.12	7.9	1.58	-24.48	-5.33
Gujarat Inject (Kerala) Ltd.	GUJINJEC	172.86	57.75	13.21	0	0
Coral Laboratories Ltd.	CORALAB	198.69	12.13	0.95	10.74	13.35

Sanjivani Paranteral Ltd. (SANJIVIN) has a P/E ratio of 27.19x compared with the displayed peer median of 18.16x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 0% compares with a peer median of 10.74% across the companies shown in the table. ROCE stood at 266.43% versus the displayed peer median of 10.17%, providing a capital-efficiency comparison. Sanjivani Paranteral Ltd. (SANJIVIN) has a market capitalisation of Rs 182.61 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

In comparison to its peers, Sanjivani Paranteral Ltd. exhibits distinct characteristics. Its P/E ratio of 27.19 is higher than that of Bio Medica Laboratories Ltd. (18.16) and Accretion Pharmaceuticals Ltd. (18.4), indicating a premium valuation. However, its P/B ratio of 3.82 is lower than Bio Medica's 9.81, suggesting a more conservative valuation relative to book value. The company's ROCE of 266.43% is a standout figure, surpassing peers like Brooks Laboratories Ltd. (-5.33%) and Gujarat Inject (Kerala) Ltd. (0%). This peer analysis underscores Sanjivani Paranteral Ltd.'s strengths and areas for growth within the competitive landscape.

Why Investors Are Watching Sanjivani Paranteral Ltd.

Investors are closely monitoring Sanjivani Paranteral Ltd. due to its recent price surge and unique positioning in the market. The company's technical and fundamental indicators provide insights into its potential trajectory.

• Price Action: 9.89% rise to Rs 165.05, surpassing micro-cap threshold.
• Technical Position: Neutral RSI at 48.98, indicating balanced momentum.
• Fundamental Context: High ROCE of 266.43%, P/E above industry median.
• Sector Positioning: Part of the competitive Pharmaceuticals & Drugs industry.

As the stock continues to attract attention, investors should monitor its performance, considering both market dynamics and company-specific developments.

About Sanjivani Paranteral Ltd.

Sanjivani Paranteral Ltd. operates in the Pharmaceuticals & Drugs industry, focusing on the development and manufacturing of healthcare products. The company is part of the broader Healthcare sector, offering a range of pharmaceutical solutions. With a market capitalisation of Rs 182.61 crore, Sanjivani Paranteral Ltd. is positioned as a micro-cap entity, navigating the competitive landscape of the industry. Its operations are geared towards innovation and efficiency, aiming to meet the evolving needs of the healthcare market. The company's strategic focus on quality and sustainability underpins its business model, driving growth and value creation in the sector.

Track Sanjivani Paranteral Ltd. Share Price on Univest

Use Sanjivani Paranteral Ltd. (SANJIVIN) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Investors can track Sanjivani Paranteral Ltd. Share Price on Univest for real-time updates and insights. Univest provides comprehensive data on technical indicators, fundamental ratios, shareholding patterns, and market insights, enabling investors to make informed decisions. Stay updated with the latest developments and trends in the Pharmaceuticals & Drugs industry through Univest's platform.

Frequently Asked Questions

What is the current share price of Sanjivani Paranteral Ltd.?

Ans. The current share price of Sanjivani Paranteral Ltd. is Rs 165.05, reflecting a 9.89% increase from the previous close of Rs 150.2. The stock moved 9.89% during the session. The intraday range extended from Rs 150 to Rs 169.

How much did Sanjivani Paranteral Ltd. share price rise today?

Ans. Sanjivani Paranteral Ltd. share price rose by 9.89% today, marking a significant gain in the micro-cap category. The stock moved 9.89% during the session. The intraday range extended from Rs 150 to Rs 169.

What is the market capitalisation of Sanjivani Paranteral Ltd.?

Ans. The market capitalisation of Sanjivani Paranteral Ltd. is Rs 182.61 crore, categorising it as a micro-cap company. The company operates in the Healthcare sector. Its P/E ratio is 27.19x. ROE is 0% and ROCE is 266.43%.

What is the P/E ratio of Sanjivani Paranteral Ltd.?

Ans. The P/E ratio of Sanjivani Paranteral Ltd. is 27.19, which is above the industry median of 18.4. The company trades at a P/E ratio of 27.19x. Its P/B ratio is 3.82x.

How does Sanjivani Paranteral Ltd.'s ROCE compare to the industry?

Ans. Sanjivani Paranteral Ltd.'s ROCE is 266.43%, significantly higher than the industry median of 12.96%. ROE stands at 0%. ROCE stands at 266.43%. The relevant peer median ROE is 9.93%. The relevant peer median ROCE is 12.96%.

What sector does Sanjivani Paranteral Ltd. operate in?

Ans. Sanjivani Paranteral Ltd. operates in the Healthcare sector, specifically within the Pharmaceuticals & Drugs industry. The stock belongs to the Healthcare sector. Its industry classification is Pharmaceuticals & Drugs. 137 comparable companies were included in the benchmark.

How does Sanjivani Paranteral Ltd.'s P/B ratio compare to peers?

Ans. Sanjivani Paranteral Ltd.'s P/B ratio of 3.82 is higher than the industry median of 1.84, indicating a premium valuation. The company trades at a P/E ratio of 27.19x. Its P/B ratio is 3.82x.